São Paulo enacts law to offer cannabis-based medicines through the SUS
Measure will facilitate access to medicines for patients who are unable to afford import costs
Tarcísio de Freitas (Republicans), governor of São Paulo, approved this Tuesday (31) the bill that aims to free distribution of cannabidiol-based medicines in the state public health network. The measure will facilitate and reduce the bureaucracy of free access to the component for patients who, until then, needed judicial authorization to receive the cannabis through SUS.
On Monday (30), deputy Caio França (PSB), author of the bill, handed the governor a petition with more than 40,000 signatures asking for the approval of PL 1180/2019. It institutes “the state policy for the free supply of cannabidiol-based plant-derived medicines, in association with other cannabinoid substances, including tetrahydrocannabidiol, on an exceptional basis by the Executive Branch, in state and private public health units associated with the System. Health System – SUS”. Once sanctioned, the law will enter into force in 90 days.
According to data from Anvisasince 2015, when the importation of cannabis-based medicines into the country was approved, requests for authorization to import the products grew more than 20 times.
A study carried out by Senate Data Research Institute in 2019 pointed out that 78% of Brazilians were favorable to the use of the herb for medicinal purposes. In addition, 75% of them agreed with the manufacture of products by the Brazilian pharmaceutical industries and 79% wanted free distribution by the SUS.
Know more: Cannabis medicine is already sold by delivery in Brazil
How cannabidiol works in the body
In a previous interview with MinhaVida, Karina Diniz, a professor at the Department of Medical Psychology and Psychiatry at Unicamp, explained that the action of cannabinoids in organisms becomes possible thanks to the existence of natural receptors for these substances.
“The components of marijuana that ‘fit’ in motor areas are responsible for the improvement of spasticity in patients with multiple sclerosis. As for those that ‘fit’ in the areas responsible for the feeling of nausea, they attenuate the effects of chemotherapy, for example”, he clarified .
Furthermore, Karina explained that when talking about cannabidiol, we should focus on expected targets. “We are not talking about lighter effects, but sought-after effects. Thus, drugs to treat muscle spasticity, for example, must contain components that act preferentially in motor areas”.
Despite this, the specialist points out that cannabidiol-based products can cause Side effectslike any other medicine.
Content for educational purposes only. Consult a Doctor.
The translator user relied on the following source:
Minha Vida Website – REF99827
Disclaimer – (English version>) This content has been prepared based on information from research, additional publications, or the translation/verification work of a volunteer editor of this web council. This is a non-profit service. It is strongly recommended that all details and information published be carefully verified. We never allow medication recommendations, medication package inserts or any medication guidance. We never allow partisan politics as information.
Isenção de responsabilidade – (versão em português): Este conteúdo foi preparado com base em informações de pesquisas, publicações adicionais ou no trabalho de tradução/verificação de um editor voluntário deste conselho web. Este é um serviço sem fins lucrativos. É altamente recomendável que todos os detalhes e informações publicadas sejam verificadas cuidadosamente. Nunca permitimos recomendações de medicamentos, bulas ou qualquer orientação sobre medicamentos. Nunca permitimos a política partidária como base para checagem. Para mais informações, leia nossos termos.